AFRM vs DNTH · P/E 590, rev $3.22B vs rev $6.2M
Affirm Holdings Inc (AFRM) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the AFRM and DNTH stock pages for the full models.
Not investment advice.